Abstract
The aim of this study was to examine genetic variations underlying the early neurodevelopmental outcome of developmental disabilities (DDs). The study cohort consisted of 191 children with DDs. Diagnosis was assessed at baseline and at the index age (72–84 months). Exome sequencing was conducted and putative risk variants were identified. According to the diagnostic improvement, children were categorized into the improvement group (n = 19) and the non-improvement group (n = 172). Compared to the non-improvement group, the improvement group had lower number of risk variants in known DD genes and haploinsufficient genes, and lower number of overall putative risk variants. Our results may serve as a preliminary basis for developing a model that informs clinical outcome by sequencing analysis.
Original language | English |
---|---|
Pages (from-to) | 2777-2783 |
Number of pages | 7 |
Journal | Journal of Autism and Developmental Disorders |
Volume | 54 |
Issue number | 7 |
DOIs | |
Publication status | Published - 2024 Jul |
Bibliographical note
Publisher Copyright:© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022.
Keywords
- Autism spectrum disorder
- Clinical improvement
- Exome sequencing
- Intellectual disability
- Neurodevelopmental outcome
ASJC Scopus subject areas
- Developmental and Educational Psychology